1. Home
  2. VFS vs RGEN Comparison

VFS vs RGEN Comparison

Compare VFS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VinFast Auto Ltd.

VFS

VinFast Auto Ltd.

HOLD

Current Price

$3.36

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$158.60

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFS
RGEN
Founded
2017
1981
Country
Vietnam
United States
Employees
N/A
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VFS
RGEN
Price
$3.36
$158.60
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$5.83
$174.90
AVG Volume (30 Days)
555.9K
680.3K
Earning Date
11-21-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$2,554,394,588.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$43.19
$12.57
P/E Ratio
N/A
$6,166.78
Revenue Growth
81.20
11.74
52 Week Low
$2.56
$102.97
52 Week High
$4.65
$182.52

Technical Indicators

Market Signals
Indicator
VFS
RGEN
Relative Strength Index (RSI) 51.79 49.17
Support Level $3.23 $156.01
Resistance Level $3.67 $165.02
Average True Range (ATR) 0.11 4.69
MACD 0.01 -1.38
Stochastic Oscillator 36.85 17.27

Price Performance

Historical Comparison
VFS
RGEN

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: